DNA Ginkgo Bioworks Holdings, Inc.

NYSE
$6.79

Ginkgo Bioworks Holdings, Inc. (DNA) is expected to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is a loss of $0.58 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -26.9% since its last earnings release on August 5, 2026.

Ginkgo Bioworks Reported Earnings
Wednesday, August 5, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.58)
Rev est $26.8M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $7.78

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Ginkgo Bioworks Holdings, Inc.

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers.

Sector

Healthcare

Industry

Biotechnology